Loading…
Lobbying Spend
—
Filings
25
Firms Hired
1
Active Period
2008–2013
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Pathway for Biosimilars Act
2009 · second_quarter · Firm: RASKY PARTNERS, INC.
HR 1548, An Act to amend the public health service act to establish a pathway for the licensure of biosimilar biological products, and for other purposes
Client expense: — · Firm income: $90,000
Matched citations: HR 1548
Pathway for Biosimilars Act
2008 · fourth_quarter · Firm: RASKY PARTNERS, INC.
HR 5629, Pathway for Biosimilars Act Legislation
Client expense: — · Firm income: $30,000
Matched citations: HR 5629
HR 5629, Pathway for Biosimilars Act Legislation
Client expense: — · Firm income: $30,000
Matched citations: HR 5629
Source: Senate LDA